CAR-T cell therapy has transformed the treatment landscape for several hematologic malignancies, offering durable responses in patients with relapsed or refractory disease. However, its unique toxicity profile requires clinicians to recognize and manage adverse effects promptly to optimize patient outcomes. Take this quick question and test your knowledge of CAR-T therapy–associated toxicities. (Scroll down to answer the question.) ##Disclaimer## The content provided on Docplexus is intended for educational purposes only.
While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data visualization elements and graphics. We do not endorse any medical treatment, product, ideas, or service, including content from our industry partners. We do not associate with the views of any individual,…
